Correction: Co-targeting the MAPK and PI3K/AKT/mTOR pathways in two genetically engineered mouse models of schwann cell tumors reduces tumor grade and multiplicity

Affiliations

• ¹ Masonic Cancer Center, University of Minnesota, Minneapolis, MN, USA.
• ² Department of Genetics, Cell Biology and Development, University of Minnesota, Minneapolis, MN, USA.
• ³ Center for Genome Engineering, University of Minnesota, Minneapolis, MN, USA.
• ⁴ Brain Tumor Program, University of Minnesota, Minneapolis, MN, USA.
• ⁵ Department of Applied Biology and Chemical Technology, The Hong Kong Polytechnic University, Hung Hom, Kowloon, Hong Kong.
• ⁶ Health and Natural Sciences Department, University of Minnesota, Minneapolis, MN, USA.
• ⁷ Division of Pathology and Laboratory Medicine, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA.
• ⁸ Department of Pediatrics, University of Minnesota, Minneapolis, MN, USA.
• ⁹ Division of Experimental Hematology and Cancer Biology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA.
• ¹⁰ Department of Pediatrics, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA.